RPAM
Rhenman & Partners Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14.5M | Sell |
27,700
-4,050
| -13% | -$2.13M | 1.84% | 20 |
|
|
2025
Q1 | $20.1M | Sell |
31,750
-11,707
| -27% | -$7.42M | 2.31% | 14 |
|
|
2024
Q4 | $31M | Buy |
43,457
+4,457
| +11% | +$3.17M | 3.18% | 5 |
|
|
2024
Q3 | $41M | Buy |
39,000
+7,000
| +22% | +$7.36M | 3.33% | 4 |
|
|
2024
Q2 | $33.6M | Sell |
32,000
-2,300
| -7% | -$2.42M | 3.23% | 5 |
|
|
2024
Q1 | $33M | Sell |
34,300
-4,700
| -12% | -$4.52M | 3.13% | 8 |
|
|
2023
Q4 | $34.3M | Sell |
39,000
-1,000
| -3% | -$878K | 3.42% | 5 |
|
|
2023
Q3 | $32.9M | Buy |
40,000
+5,000
| +14% | +$4.11M | 3.55% | 4 |
|
|
2023
Q2 | $25.1M | Sell |
35,000
-500
| -1% | -$359K | 2.65% | 9 |
|
|
2023
Q1 | $28.8M | Sell |
35,500
-1,500
| -4% | -$1.22M | 3.16% | 4 |
|
|
2022
Q4 | $26.7M | Buy |
37,000
+5,000
| +16% | +$3.61M | 2.79% | 5 |
|
|
2022
Q3 | $24M | Buy |
32,000
+18,000
| +129% | +$13.5M | 2.51% | 8 |
|
|
2022
Q2 | $8.28M | Sell |
14,000
-14,500
| -51% | -$8.57M | 0.94% | 40 |
|
|
2022
Q1 | $19.9M | Buy |
+28,500
| New | +$19.9M | 1.96% | 16 |
|
|
2021
Q3 | – | Sell |
-25,000
| Closed | -$14M | – | 95 |
|
|
2021
Q2 | $14M | Buy |
25,000
+5,000
| +25% | +$2.79M | 0.95% | 45 |
|
|
2021
Q1 | $9.46M | Sell |
20,000
-20,000
| -50% | -$9.46M | 0.66% | 50 |
|
|
2020
Q4 | $19.3M | Buy |
40,000
+17,500
| +78% | +$8.45M | 1.58% | 26 |
|
|
2020
Q3 | $12.6M | Buy |
22,500
+10,000
| +80% | +$5.6M | 1.12% | 38 |
|
|
2020
Q2 | $7.8M | Buy |
+12,500
| New | +$7.8M | 0.84% | 48 |
|
|
2020
Q1 | – | Sell |
-27,000
| Closed | -$10.1M | – | 93 |
|
|
2019
Q4 | $10.1M | Sell |
27,000
-18,031
| -40% | -$6.77M | 1.11% | 39 |
|
|
2019
Q3 | $12.5M | Buy |
45,031
+17
| +0% | +$4.72K | 1.57% | 25 |
|
|
2019
Q2 | $14.1M | Buy |
45,014
+29,014
| +181% | +$9.08M | 1.55% | 29 |
|
|
2019
Q1 | $6.57M | Sell |
16,000
-1,000
| -6% | -$411K | 0.77% | 53 |
|
|
2018
Q4 | $6.35M | Hold |
17,000
| – | – | 0.73% | 52 |
|
|
2018
Q3 | $6.87M | Hold |
17,000
| – | – | 0.69% | 56 |
|
|
2018
Q2 | $5.87M | Sell |
17,000
-17,000
| -50% | -$5.87M | 0.6% | 57 |
|
|
2018
Q1 | $11.7M | Buy |
34,000
+2,846
| +9% | +$980K | 1.44% | 29 |
|
|
2017
Q4 | $11.7M | Buy |
31,154
+9,154
| +42% | +$3.44M | 1.58% | 25 |
|
|
2017
Q3 | $9.84M | Buy |
22,000
+6,900
| +46% | +$3.09M | 1.26% | 31 |
|
|
2017
Q2 | $7.42M | Sell |
15,100
-21,900
| -59% | -$10.8M | 1.06% | 37 |
|
|
2017
Q1 | $14.3M | Buy |
37,000
+10,500
| +40% | +$4.07M | 2.27% | 9 |
|
|
2016
Q4 | $9.73M | Sell |
26,500
-3,000
| -10% | -$1.1M | 1.86% | 18 |
|
|
2016
Q3 | $11.9M | Sell |
29,500
-20,000
| -40% | -$8.04M | 1.88% | 17 |
|
|
2016
Q2 | $17.3M | Buy |
49,500
+37,500
| +313% | +$13.1M | 3.07% | 6 |
|
|
2016
Q1 | $4.33M | Sell |
12,000
-9,000
| -43% | -$3.24M | 0.86% | 45 |
|
|
2015
Q4 | $11.4M | Buy |
21,000
+4,500
| +27% | +$2.44M | 1.72% | 21 |
|
|
2015
Q3 | $7.68M | Sell |
16,500
-2,500
| -13% | -$1.16M | 1.22% | 34 |
|
|
2015
Q2 | $9.69M | Sell |
19,000
-3,000
| -14% | -$1.53M | 1.16% | 22 |
|
|
2015
Q1 | $9.93M | Sell |
22,000
-500
| -2% | -$226K | 1.67% | 18 |
|
|
2014
Q4 | $9.23M | Buy |
22,500
+9,500
| +73% | +$3.9M | 2.68% | 4 |
|
|
2014
Q3 | $4.6M | Sell |
13,000
-9,500
| -42% | -$3.36M | 1.35% | 22 |
|
|
2014
Q2 | $6.36M | Sell |
22,500
-33,292
| -60% | -$9.4M | 1.89% | 12 |
|
|
2014
Q1 | $16.8M | Buy |
55,792
+18,792
| +51% | +$5.64M | 5.03% | 3 |
|
|
2013
Q4 | $10.2M | Buy |
+37,000
| New | +$10.2M | 3.98% | 1 |
|